{"id":554527,"date":"2026-04-13T02:00:00","date_gmt":"2026-04-13T00:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/incretino-mimetiques-en-cas-de-comorbidites-telles-que-diabete-de-type-2-ascvd-hf-osas\/"},"modified":"2026-04-17T16:18:09","modified_gmt":"2026-04-17T14:18:09","slug":"incretino-mimetiques-en-cas-de-comorbidites-telles-que-diabete-de-type-2-ascvd-hf-osas","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/incretino-mimetiques-en-cas-de-comorbidites-telles-que-diabete-de-type-2-ascvd-hf-osas\/","title":{"rendered":"Incr\u00e9tino-mim\u00e9tiques en cas de comorbidit\u00e9s telles que diab\u00e8te de type 2, ASCVD, HF, OSAS"},"content":{"rendered":"\n

Les mesures li\u00e9es au mode de vie constituent la base du traitement du surpoids et de l’ob\u00e9sit\u00e9. Cependant, pour atteindre et maintenir le poids cible vis\u00e9, des mesures pharmacologiques ou chirurgicales concomitantes sont g\u00e9n\u00e9ralement n\u00e9cessaires. La pharmacoth\u00e9rapie est devenue un \u00e9l\u00e9ment central de la prise en charge globale de l’ob\u00e9sit\u00e9, l’accent \u00e9tant mis sur les th\u00e9rapies \u00e0 base d’incr\u00e9tines. Ils permettent une r\u00e9duction efficace du poids et des \u00e9tudes r\u00e9centes ont \u00e9galement d\u00e9montr\u00e9 des effets b\u00e9n\u00e9fiques sur diverses maladies concomitantes qui sont plus fr\u00e9quentes chez les patients ob\u00e8ses. <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Les mesures li\u00e9es au mode de vie constituent la base du traitement du surpoids et de l’ob\u00e9sit\u00e9. Cependant, pour atteindre et maintenir le poids cible vis\u00e9, des mesures pharmacologiques ou……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":554528,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Traitement de l'ob\u00e9sit\u00e9 : nouvelles donn\u00e9es d'\u00e9tude","footnotes":""},"category":[11378,11404,11315,11410,11464,11477,11535,11549],"tags":[75163,13750,12050,14226,90482,12410,17807,17458,81085,72440],"powerkit_post_featured":[],"class_list":["post-554527","post","type-post","status-publish","format-standard","has-post-thumbnail","category-cardiologie","category-endocrinologie-et-diabetologie","category-medecine-interne-generale","category-nutrition-fr","category-pharmacologie-et-toxicologie","category-pneumologie-fr","category-rapports-de-congres","category-rx-fr","tag-ascvd-fr","tag-comorbidites-fr","tag-diabete-de-type-2","tag-hf-fr","tag-incretino-mimetiques","tag-obesite","tag-osas-fr","tag-semaglutid-fr","tag-surmount-fr","tag-tirzepatide-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-25 23:57:26","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":554524,"slug":"i-mimetici-dellincretina-per-le-comorbidita-come-il-diabete-di-tipo-2-lascvd-lhf-losas","post_title":"I mimetici dell'incretina per le comorbidit\u00e0 come il diabete di tipo 2, l'ASCVD, l'HF, l'OSAS.","href":"https:\/\/medizinonline.com\/it\/i-mimetici-dellincretina-per-le-comorbidita-come-il-diabete-di-tipo-2-lascvd-lhf-losas\/"},"pt_PT":{"locale":"pt_PT","id":554485,"slug":"mimeticos-da-incretina-para-comorbilidades-como-a-diabetes-tipo-2-ascvd-hf-saos","post_title":"Mim\u00e9ticos da incretina para comorbilidades como a diabetes tipo 2, ASCVD, HF, SAOS","href":"https:\/\/medizinonline.com\/pt-pt\/mimeticos-da-incretina-para-comorbilidades-como-a-diabetes-tipo-2-ascvd-hf-saos\/"},"es_ES":{"locale":"es_ES","id":554521,"slug":"mimeticos-de-la-incretina-para-comorbilidades-como-diabetes-tipo-2-ascvd-ic-osas","post_title":"Mim\u00e9ticos de la incretina para comorbilidades como diabetes tipo 2, ASCVD, IC, OSAS","href":"https:\/\/medizinonline.com\/es\/mimeticos-de-la-incretina-para-comorbilidades-como-diabetes-tipo-2-ascvd-ic-osas\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/554527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=554527"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/554527\/revisions"}],"predecessor-version":[{"id":554529,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/554527\/revisions\/554529"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/554528"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=554527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=554527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=554527"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=554527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}